Sanctuary Advisors’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$909K Buy
6,062
+957
+19% +$104K ﹤0.01% 1520
2026
Q1
$472K Buy
5,105
+12
+0.2% +$1.21K ﹤0.01% 1820
2025
Q4
$520K Sell
5,093
-1,197
-19% -$107K ﹤0.01% 1701
2025
Q3
$393K Buy
6,290
+1,831
+41% +$99.6K ﹤0.01% 1841
2025
Q2
$232K Buy
+4,459
New +$199K ﹤0.01% 2077

Other funds holding GH

Sanctuary Advisors's GH Position: Q2 2026 in Review

Sanctuary Advisors increased its Guardant Health (GH) stake by 19% in Q2 2026, buying an estimated $104K and bringing the position to 6,062 shares worth $909K. The position accounts for ﹤0.01% of the portfolio, ranked #1520.

Sanctuary Advisors first reported a position in GH in Q2 2025 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Sanctuary Advisors held 6,062 shares of Guardant Health worth $909K as of Q2 2026.
  • Sanctuary Advisors bought 957 Guardant Health shares in Q2 2026, an estimated $104K.
  • Guardant Health made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1520 holding.
  • Sanctuary Advisors first reported a position in Guardant Health in Q2 2025 and has held it in 5 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.